Back to search
Autoimmune Lymphoproliferative Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Lymphoproliferative Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Autoimmune Lymphoproliferative Syndrome trials you may qualify forBackground: Autoimmune lymphoproliferative syndrome (ALPS) is a rare disorder of the immune system caused by a mutation in the FAS gene. In ALPS, the body stor…
Background: During a transplant, blood stem cells from one person are given to someone else. The cells grow into the different cells that make up the immune sy…
The investigators hypothesize that hypogammaglobulinemia (defined as IgG serum concentration \<7.0g/L) is a treatable cause of fatigue in people with MS: The p…
The purpose of the protocol is to allow for patients, and relatives of patients, who may have the newly described autoimmune lymphoproliferative syndrome, to be…
Background: Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow and given to another person. Researchers…
The main purpose of study is to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of benralizumab.
The purpose of this study is to find out whether hydroxychloroquine, in addition to background treatments, reduces disease activity in patients with Anti-Neutro…
RACEMATE is a phase 2b, multicentre, randomised, double-blinded, placebo-controlled study designed to explore the efficacy and mechanism of action of tezepeluma…
The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and…